Literature DB >> 10803591

Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element.

G Canettieri1, F S Celi, G Baccheschi, L Salvatori, M Andreoli, M Centanni.   

Abstract

We analyzed the structure and function of the 5' flanking region of the human type 2 deiodinase (hD2) gene. Two major transcription start sites were identified at -470/-474 from the ATG. The 5' flanking region of hD2 gene efficiently directed transcription in transient transfection studies, using luciferase as reporter gene, in HEK 293 cells. Basal transcriptional activity was significantly reduced by deleting the region containing a canonical cAMP-responsive element (CRE) located -766/-759 from ATG. Forskolin treatment significantly increased luciferase activity in cells transfected with CRE-containing constructs. This effect was abolished in constructs that did not contain CRE or contained the mutagenized CRE. Northern blot analysis in JEG-3 cells revealed that the hD2 messenger RNA was markedly increased after stimulation with cAMP agonist. The electrophoretic mobility shift assay with hD2-CRE probe and HEK 293 nuclear extract showed the occurrence of a DNA-protein complex, which was competed by specific unlabeled oligonucleotides and supershifted by the anti-CREB and anti-CRE modulator-1 antibodies. A-CREB, a dominant negative inhibitor of CREB, completely inhibited forskolin induction of the hD2 promoter. CREB protein, once cotransfected with hD2 promoter construct and pKA in F9 teratocarcinoma cells, which are unresponsive to cAMP, was able to stimulate the hD2 gene transcription. These results indicate the existence of a functional promoter within the 5' flanking region of hD2 gene which is characterized by the presence of a CRE. The specific involvement of CREB in the cAMP-mediated hD2 gene promoter induction also has been demonstrated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803591     DOI: 10.1210/endo.141.5.7471

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH.

Authors:  Maya Y Peltsverger; Peter W Butler; Anna Teresa Alberobello; Sheila Smith; Yanina Guevara; Ornella M Dubaz; Javier A Luzon; Joyce Linderman; Francesco S Celi
Journal:  Eur J Endocrinol       Date:  2012-02-03       Impact factor: 6.664

2.  The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.

Authors:  Francesco S Celi; Giuseppe Coppotelli; Aaron Chidakel; Marilyn Kelly; Beth A Brillante; Thomas Shawker; Natasha Cherman; Penelope P Feuillan; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

Review 3.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

4.  A Low-Protein, High-Carbohydrate Diet Stimulates Thermogenesis in the Brown Adipose Tissue of Rats via ATF-2.

Authors:  Suélem A de França; Maísa P dos Santos; Franciele Przygodda; Maria Antonieta R Garófalo; Isis C Kettelhut; Diego A Magalhães; Kalinne S Bezerra; Edson M Colodel; Andreas D Flouris; Cláudia M B Andrade; Nair H Kawashita
Journal:  Lipids       Date:  2016-01-19       Impact factor: 1.880

Review 5.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

6.  CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell line.

Authors:  Gianluca Canettieri; Maria Giulia Santaguida; Laura Antonucci; Michele Della Guardia; Antonella Franchi; Sonia Coni; Alberto Gulino; Marco Centanni
Journal:  Endocrinology       Date:  2012-06-11       Impact factor: 4.736

7.  Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cells.

Authors:  Gianluca Canettieri; Antonella Franchi; Michele Della Guardia; Ianessa Morantte; Maria Giulia Santaguida; John W Harney; P Reed Larsen; Marco Centanni
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

8.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

Review 9.  Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling.

Authors:  Rafael Arrojo E Drigo; Tatiana L Fonseca; Joao Pedro Saar Werneck-de-Castro; Antonio C Bianco
Journal:  Biochim Biophys Acta       Date:  2012-08-29

10.  Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid.

Authors:  Nagaoki Toyoda; Saori Yasuzawa-Amano; Emiko Nomura; Azusa Yamauchi; Kumiko Nishimura; Chizuko Ukita; Satoshi Morimoto; Atsushi Kosaki; Toshiji Iwasaka; John W Harney; P Reed Larsen; Mitsushige Nishikawa
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.